<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33963840</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>05</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2160-1836</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>Aug</Month><Day>07</Day></PubDate></JournalIssue><Title>G3 (Bethesda, Md.)</Title><ISOAbbreviation>G3 (Bethesda)</ISOAbbreviation></Journal><ArticleTitle>Human Ubiquilin 2 and TDP-43 copathology drives neurodegeneration in transgenic Caenorhabditis elegans.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">jkab158</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/g3journal/jkab158</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a debilitating, fatal neurodegenerative disease that causes rapid muscle wasting. It shares a spectrum of symptoms and pathology with frontotemporal lobar degeneration (FTLD). These diseases are caused by aberrant activity of a set of proteins including TDP-43 and UBIQUILIN-2 (UBQLN2). UBQLN2 encodes a ubiquitin-like adaptor protein involved in the ubiquitin-proteasome protein degradation pathway. Mutations in the PXX domain of UBQLN2 cause familial ALS. UBQLN2 aggregates in skein-like inclusions with other ALS and FTLD associated proteins including TDP-43 and ubiquitin. To facilitate further investigation of UBQLN2-mediated mechanisms of neurodegeneration, we made Caenorhabditis elegans transgenic lines pan-neuronally expressing human UBQLN2 cDNAs carrying either the wild-type UBQLN2 sequence or UBQLN2 with ALS causing mutations. Transgenic animals exhibit motor dysfunction accompanied by neurodegeneration of GABAergic motor neurons. At low levels of UBQLN2 expression, wild-type UBQLN2 causes significant motor impairment and neurodegeneration that is exacerbated by ALS associated mutations in UBQLN2. At higher levels of UBQLN2 expression, both wild-type and ALS mutated versions of UBQLN2 cause severe impairment. Molecular genetic investigation revealed that UBQLN2 dependent locomotor defects do not require the involvement of the endogenous homolog of TDP-43 in C. elegans (tdp-1). However, co-expression of wild-type human TDP-43 exacerbates UBQLN2 deficits. This model of UBQLN2-mediated neurodegeneration may be useful for further mechanistic investigation into the molecular cascades driving neurodegeneration in ALS and ALS-FTLD.</AbstractText><CopyrightInformation>Published by Oxford University Press on behalf of Genetics Society of America 2021.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Saxton</LastName><ForeName>Aleen D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Geriatrics Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA 98108, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kraemer</LastName><ForeName>Brian C</ForeName><Initials>BC</Initials><Identifier Source="ORCID">0000-0002-2252-7634</Identifier><AffiliationInfo><Affiliation>Geriatrics Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA 98108, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Gerontology and Geriatric Medicine, Department of Medicine, University of Washington School of Medicine, Seattle, WA 98104, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA 98195, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA 98195, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>I01 BX003755</GrantID><Acronym>BX</Acronym><Agency>BLRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS064131</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>G3 (Bethesda)</MedlineTA><NlmUniqueID>101566598</NlmUniqueID><ISSNLinking>2160-1836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D048868">Adaptor Proteins, Signal Transducing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071183">Autophagy-Related Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C405662">UBQLN2 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D048868" MajorTopicYN="N">Adaptor Proteins, Signal Transducing</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030801" MajorTopicYN="N">Animals, Genetically Modified</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071183" MajorTopicYN="N">Autophagy-Related Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017173" MajorTopicYN="Y">Caenorhabditis elegans</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057174" MajorTopicYN="N">Frontotemporal Lobar Degeneration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">
          C. elegans
        </Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">UBQLN2</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">transgenic</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>8</Day><Hour>12</Hour><Minute>6</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33963840</ArticleId><ArticleId IdType="pmc">PMC8496285</ArticleId><ArticleId IdType="doi">10.1093/g3journal/jkab158</ArticleId><ArticleId IdType="pii">6272515</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alexander EJ, Ghanbari Niaki A, Zhang T, Sarkar J, Liu Y, et al.2018. Ubiquilin 2 modulates ALS/FTD-linked FUS-RNA complex dynamics and stress granule formation. Proc Natl Acad Sci USA. 115:E11485&#x2013;E11494.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6298105</ArticleId><ArticleId IdType="pubmed">30442662</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner S. 1974. The genetics of Caenorhabditis elegans. Genetics. 77:71&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1213120</ArticleId><ArticleId IdType="pubmed">4366476</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassel JA, Reitz AB.. 2013. Ubiquilin-2 (UBQLN2) binds with high affinity to the C-terminal region of TDP-43 and modulates TDP-43 levels in H4 cells: characterization of inhibition by nucleic acids and 4-aminoquinolines. Biochim Biophys Acta. 1834:964&#x2013;971.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3960997</ArticleId><ArticleId IdType="pubmed">23541532</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceballos-Diaz C, Rosario AM, Park HJ, Chakrabarty P, Sacino A, et al.2015. Viral expression of ALS-linked ubiquilin-2 mutants causes inclusion pathology and behavioral deficits in mice. Mol Neurodegener. 10:25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4495639</ArticleId><ArticleId IdType="pubmed">26152284</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L, Monteiro MJ.. 2015. Defective proteasome delivery of polyubiquitinated proteins by ubiquilin-2 proteins containing ALS mutations. PLoS One. 10:e0130162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4468220</ArticleId><ArticleId IdType="pubmed">26075709</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T, Huang B, Shi X, Gao L, Huang C.. 2018. Mutant UBQLN2(P497h) in motor neurons leads to ALS-like phenotypes and defective autophagy in rats. Acta Neuropathol Commun. 6:122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6225656</ArticleId><ArticleId IdType="pubmed">30409191</ArticleId></ArticleIdList></Reference><Reference><Citation>Crippa V, Sau D, Rusmini P, Boncoraglio A, Onesto E, et al.2010. The small heat shock protein b8 (Hspb8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS). Hum Mol Genet. 19:3440&#x2013;3456.</Citation><ArticleIdList><ArticleId IdType="pubmed">20570967</ArticleId></ArticleIdList></Reference><Reference><Citation>Dao TP, Martyniak B, Canning AJ, Lei Y, Colicino EG, et al.2019. ALS-linked mutations affect UBQLN2 oligomerization and phase separation in a position- and amino acid-dependent manner. Structure. 27:937&#x2013;951. e935.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6551275</ArticleId><ArticleId IdType="pubmed">30982635</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng HX, Chen W, Hong ST, Boycott KM, Gorrie GH, et al.2011. Mutations in UBQLN2 cause dominant x-linked juvenile and adult-onset als and als/dementia. Nature. 477:211&#x2013;215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3169705</ArticleId><ArticleId IdType="pubmed">21857683</ArticleId></ArticleIdList></Reference><Reference><Citation>Dokshin GA, Ghanta KS, Piscopo KM, Mello CC.. 2018. Robust genome editing with short single-stranded and long, partially single-stranded DNA donors in Caenorhabditis elegans. Genetics. 210:781&#x2013;787.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6218216</ArticleId><ArticleId IdType="pubmed">30213854</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahed AC, McDonough B, Gouvion CM, Newell KL, Dure LS, et al.2014. UBQLN2 mutation causing heterogeneous x-linked dominant neurodegeneration. Ann Neurol. 75:793&#x2013;798.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4106259</ArticleId><ArticleId IdType="pubmed">24771548</ArticleId></ArticleIdList></Reference><Reference><Citation>Gellera C, Tiloca C, Del Bo R, Corrado L, Pensato V, et al.2013. UBIQUILIN 2 mutations in Italian patients with amyotrophic lateral sclerosis and frontotemporal dementia. J Neurol Neurosurg Psychiatry. 84:183&#x2013;187.</Citation><ArticleIdList><ArticleId IdType="pubmed">23138764</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorrie GH, Fecto F, Radzicki D, Weiss C, Shi Y, et al.2014. Dendritic spinopathy in transgenic mice expressing als/dementia-linked mutant UBQLN2. Proc Natl Acad Sci USA. 111:14524&#x2013;14529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4209984</ArticleId><ArticleId IdType="pubmed">25246588</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson KA, Kim SH, Wassarman DA, Tibbetts RS.. 2010. Ubiquilin modifies TDP-43 toxicity in a Drosophila model of amyotrophic lateral sclerosis (ALS). J Biol Chem. 285:11068&#x2013;11072.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2856981</ArticleId><ArticleId IdType="pubmed">20154090</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjerpe R, Bett JS, Keuss MJ, Solovyova A, McWilliams TG, Johnson C, et al.2016. UBQLN2 mediates autophagy-independent protein aggregate clearance by the proteasome. Cell. 166:935&#x2013;949.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5003816</ArticleId><ArticleId IdType="pubmed">27477512</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaye FJ, Modi S, Ivanovska I, Koonin EV, Thress K, et al.2000. A family of ubiquitin-like proteins binds the ATPase domain of Hsp70-like Stch. FEBS Lett. 467:348&#x2013;355.</Citation><ArticleIdList><ArticleId IdType="pubmed">10675567</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaye FJ, Shows TB.. 2000. Assignment of Ubiquilin2 (UBQLN2) to human chromosome xp11. 23&#x2013;&gt;p11.1 by genebridge radiation hybrids. Cytogenet Genome Res. 89:116&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pubmed">10894951</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SH, Stiles SG, Feichtmeier JM, Ramesh N, Zhan L, et al.2018. Mutation-dependent aggregation and toxicity in a Drosophila model for UBQLN2-associated als. Hum Mol Genet. 27:322&#x2013;337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5886165</ArticleId><ArticleId IdType="pubmed">29161404</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleijnen MF, Alarcon RM, Howley PM.. 2003. The ubiquitin-associated domain of hPLIC-2 interacts with the proteasome. Mol Biol Cell. 14:3868&#x2013;3875.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC196580</ArticleId><ArticleId IdType="pubmed">12972570</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleijnen MF, Shih AH, Zhou P, Kumar S, Soccio RE, et al.2000. The hPLIC proteins may provide a link between the ubiquitination machinery and the proteasome. Mol Cell. 6:409&#x2013;419.</Citation><ArticleIdList><ArticleId IdType="pubmed">10983987</ArticleId></ArticleIdList></Reference><Reference><Citation>Le NT, Chang L, Kovlyagina I, Georgiou P, Safren N, et al.2016. Motor neuron disease, TDP-43 pathology, and memory deficits in mice expressing ALS-FTD-linked UBQLN2 mutations. Proc Natl Acad Sci USA. 113:E7580&#x2013;E7589.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5127348</ArticleId><ArticleId IdType="pubmed">27834214</ArticleId></ArticleIdList></Reference><Reference><Citation>Liachko NF, McMillan PJ, Strovas TJ, Loomis E, Greenup L, . et al. 2014. The tau tubulin kinases TTBK1/2 promote accumulation of pathological TDP-43. PLoS Genet. 10:e1004803.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4256087</ArticleId><ArticleId IdType="pubmed">25473830</ArticleId></ArticleIdList></Reference><Reference><Citation>Liachko NF, Guthrie CR, Kraemer BC.. 2010. Phosphorylation promotes neurotoxicity in a Caenorhabditis elegans model of TDP-43 proteinopathy. J Neurosci. 30:16208&#x2013;16219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3075589</ArticleId><ArticleId IdType="pubmed">21123567</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Kwong LK, Lee EB, Kremmer E, Flatley A, et al.2009. Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol. 117:137&#x2013;149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2693625</ArticleId><ArticleId IdType="pubmed">19125255</ArticleId></ArticleIdList></Reference><Reference><Citation>Paix A, Folkmann A, Rasoloson D, Seydoux G.. 2015. High efficiency, homology-directed genome editing in Caenorhabditis elegans using crispr-cas9 ribonucleoprotein complexes. Genetics. 201:47&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4566275</ArticleId><ArticleId IdType="pubmed">26187122</ArticleId></ArticleIdList></Reference><Reference><Citation>Picher-Martel V, Dutta K, Phaneuf D, Sobue G, Julien JP.. 2015. Ubiquilin-2 drives NF-&#x3ba; b activity and cytosolic TDP-43 aggregation in neuronal cells. Mol Brain. 8:71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4628361</ArticleId><ArticleId IdType="pubmed">26521126</ArticleId></ArticleIdList></Reference><Reference><Citation>Rechtman L, Jordan H, Wagner L, Horton DK, Kaye W.. 2015. Racial and ethnic differences among amyotrophic lateral sclerosis cases in the united states. Amyotroph Lateral Scler Frontotemporal Degener. 16:65&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4389704</ArticleId><ArticleId IdType="pubmed">25482100</ArticleId></ArticleIdList></Reference><Reference><Citation>Robatzek M, Thomas JH.. 2000. Calcium/calmodulin-dependent protein kinase II regulates Caenorhabditis elegans locomotion in concert with a G(o)/G(q) signaling network. Genetics. 156:1069&#x2013;1082.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1461315</ArticleId><ArticleId IdType="pubmed">11063685</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharkey LM, Safren N, Pithadia AS, Gerson JE, Dulchavsky M, et al.2018. Mutant UBQLN2 promotes toxicity by modulating intrinsic self-assembly. Proc Natl Acad Sci USA. 115:E10495&#x2013;E10504.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6217421</ArticleId><ArticleId IdType="pubmed">30333186</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan RH, Ke YD, Ittner LM, Halliday GM.. 2017. ALS/FTLD: experimental models and reality. Acta Neuropathol. 133:177&#x2013;196.</Citation><ArticleIdList><ArticleId IdType="pubmed">28058507</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanden Broeck L, Callaerts P, Dermaut B.. 2014. TDP-43-mediated neurodegeneration: towards a loss-of-function hypothesis? Trends Mol Med. 20:66&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">24355761</ArticleId></ArticleIdList></Reference><Reference><Citation>Walters KJ, Lech PJ, Goh AM, Wang Q, Howley PM.. 2003. DNA-repair protein hHR23a alters its protein structure upon binding proteasomal subunit S5a. Proc Natl Acad Sci USA. 100:12694&#x2013;12699.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC240680</ArticleId><ArticleId IdType="pubmed">14557549</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams KL, Warraich ST, Yang S, Solski JA, Fernando R, et al.2012. UBQLN2/ubiquilin 2 mutation and pathology in familial amyotrophic lateral sclerosis. Neurobiol Aging. 33:2527.e3&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">22717235</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q, Liu M, Huang C, Liu X, Huang B, et al.2015. Pathogenic Ubqln2 gains toxic properties to induce neuron death. Acta Neuropathol. 129:417&#x2013;428.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4777328</ArticleId><ArticleId IdType="pubmed">25388785</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu ZS. 2012. Does a loss of TDP-43 function cause neurodegeneration? Mol Neurodegener. 7:27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3419078</ArticleId><ArticleId IdType="pubmed">22697423</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang KY, Yang S, Warraich ST, Blair IP.. 2014. Ubiquilin 2: a component of the ubiquitin-proteasome system with an emerging role in neurodegeneration. Int J Biochem Cell Biol. 50:123&#x2013;126.</Citation><ArticleIdList><ArticleId IdType="pubmed">24589709</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>